ketoconazole has been researched along with Black Fever in 20 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of a renal transplant recipient who developed pancreatitis during stibogluconate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported." | 7.68 | Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. ( al-Eisa, A; Alfurayh, O; Damanhouri, G; Dammas, S; Halim, MA; Kalin, ME, 1993) |
| "Acute pancreatitis is a rarely reported adverse effect." | 5.31 | Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. ( Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T, 2001) |
| "Amphotericin B is used for the treatment of systemic mycoses and visceral leishmaniasis." | 3.71 | No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes. ( Azas, N; Delmas, F; Di Giorgio, C; Gasquet, M; Timon-David, P, 2001) |
| "A case of a renal transplant recipient who developed pancreatitis during stibogluconate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported." | 3.68 | Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. ( al-Eisa, A; Alfurayh, O; Damanhouri, G; Dammas, S; Halim, MA; Kalin, ME, 1993) |
| " However, no serious side effect were noted in all of the patients during treatment." | 2.67 | The efficacy and safety of ketoconazole in visceral leishmaniasis. ( Gachihi, GS; Kirigi, G; Mbugua, J; Nyakundi, PM; Rashid, JR; Wasunna, KM, 1994) |
| "Acute pancreatitis is a rarely reported adverse effect." | 1.31 | Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. ( Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T, 2001) |
| "Ketoconazole was shown to be effective against imported cutaneous leishmaniasis." | 1.30 | Imported cutaneous leishmaniasis in Thailand. ( Punpoowong, B; Riganti, M; Viravan, C; Viriyavejakul, P, 1997) |
| " orally in divided dosage for 30 days." | 1.29 | Combination therapy in Kala-azar. ( Jha, S; Jha, TK; Singh, IJ; Singh, NK, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (80.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanys-Muñoz, E | 1 |
| Pérez-Victoria, JM | 1 |
| Gamarro, F | 1 |
| Castanys, S | 1 |
| Shakya, N | 1 |
| Sane, SA | 1 |
| Vishwakarma, P | 1 |
| Bajpai, P | 1 |
| Gupta, S | 1 |
| Ramesh, V | 2 |
| Mukherjee, A | 1 |
| Rashid, JR | 1 |
| Wasunna, KM | 1 |
| Gachihi, GS | 1 |
| Nyakundi, PM | 1 |
| Mbugua, J | 1 |
| Kirigi, G | 1 |
| Chandra, J | 1 |
| Patwari, AK | 1 |
| Halim, MA | 1 |
| Alfurayh, O | 1 |
| Kalin, ME | 1 |
| Dammas, S | 1 |
| al-Eisa, A | 1 |
| Damanhouri, G | 1 |
| Ahasan, HA | 1 |
| Rafiqueuddin, AK | 1 |
| Azhar, MA | 1 |
| Chowdhury, MA | 1 |
| Singh, NK | 2 |
| Jha, TK | 2 |
| Singh, IJ | 1 |
| Jha, S | 2 |
| Wali, JP | 3 |
| Aggarwal, P | 3 |
| Nandy, A | 1 |
| Singh, S | 3 |
| Addy, M | 1 |
| Guha, SK | 1 |
| Dwivedi, SN | 1 |
| Karmarkar, MG | 1 |
| Maji, AK | 1 |
| Viriyavejakul, P | 1 |
| Viravan, C | 1 |
| Riganti, M | 1 |
| Punpoowong, B | 1 |
| Hueso, M | 1 |
| Bover, J | 1 |
| Serón, D | 1 |
| Gil-Vernet, S | 1 |
| Rufí, G | 1 |
| Alsina, J | 1 |
| Grinyó, JM | 1 |
| Kuyucu, N | 1 |
| Kara, C | 1 |
| Bakirtaç, A | 1 |
| Teziç, T | 1 |
| Azas, N | 1 |
| Di Giorgio, C | 1 |
| Delmas, F | 1 |
| Gasquet, M | 1 |
| Timon-David, P | 1 |
| Lafeuillade, A | 1 |
| Chaffanjon, P | 1 |
| Delbeke, E | 1 |
| Quilichini, R | 1 |
| Zijlstra, EE | 1 |
| Saxena, U | 1 |
| Misra, RS | 1 |
| Gupta, U | 2 |
| Saluja, S | 2 |
| Andreo, JA | 1 |
| Vivancos, F | 1 |
| Serrano, P | 1 |
| Soriano, J | 1 |
2 reviews available for ketoconazole and Black Fever
| Article | Year |
|---|---|
Post-kala-azar dermal leishmaniasis.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Humans; Incidence; Ketoconazole; Leishmanias | 1995 |
Diagnosis and treatment of kala-azar.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Child; Combined Modality Therapy; Humans; Ke | 1994 |
4 trials available for ketoconazole and Black Fever
| Article | Year |
|---|---|
The efficacy and safety of ketoconazole in visceral leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Body Weight; Child; Female; Hemoglobins; Humans; Ketoconazo | 1994 |
Ketoconazole in the treatment of visceral leishmaniasis (kala-azar)
Topics: Administration, Oral; Antiprotozoal Agents; Follow-Up Studies; Humans; Ketoconazole; Leishmaniasis, | 1996 |
Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar--a comparative study.
Topics: Drug Monitoring; Follow-Up Studies; Hepatomegaly; Humans; Ketoconazole; Leishmaniasis, Visceral; Liv | 1997 |
The treatment of kala-azar: old and new options.
Topics: Amphotericin B; Antimony; Humans; Ketoconazole; Leishmaniasis, Visceral; Paromomycin | 1992 |
14 other studies available for ketoconazole and Black Fever
| Article | Year |
|---|---|
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Base Sequence; Bi | 2008 |
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Disease Models, Animal; Drug Therapy, Combina | 2011 |
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
Topics: Adult; Allopurinol; Antimony Sodium Gluconate; Drug Therapy, Combination; Female; Humans; Ketoconazo | 1993 |
Combination therapy in Kala-azar.
Topics: Adult; Allopurinol; Antimony Sodium Gluconate; Antiprotozoal Agents; Dose-Response Relationship, Dru | 1995 |
Ketoconazole in antimonial unresponsive cases of Kala-azar.
Topics: Adult; Animals; Antifungal Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; | 1995 |
Imported cutaneous leishmaniasis in Thailand.
Topics: Adult; Humans; Ketoconazole; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Retrospective | 1997 |
The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Topics: Aged; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Ketoconazole; Kidney Tra | 1999 |
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmania | 2001 |
No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes.
Topics: Amphotericin B; Animals; Antifungal Agents; Antioxidants; Antiprotozoal Agents; Ascorbic Acid; Catal | 2001 |
Maintenance itraconazole for visceral leishmaniasis in HIV infection.
Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Leishmaniasis, | 1992 |
Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
Topics: Adult; Humans; Ketoconazole; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male | 1992 |
Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar.
Topics: Antimony; Drug Resistance; Humans; Ketoconazole; Leishmaniasis, Visceral; Pentamidine | 1992 |
[Visceral leishmaniasis with partial response to ketoconazole in a patient with positive antibodies to the human immunodeficiency virus].
Topics: Adult; Chronic Disease; HIV Infections; HIV Seropositivity; HIV-1; Humans; Ketoconazole; Leishmanias | 1991 |
Ketoconazole in treatment of visceral leishmaniasis.
Topics: Adolescent; Adult; Drug Administration Schedule; Female; Humans; Ketoconazole; Leishmaniasis, Viscer | 1990 |